Benchling Stock

HealthTech

Looking to sell Benchling stock or options?

Founded: 2012Funding to Date: $425M

Benchling is a developer of a laboratory collaboration platform that aims to expedite and enhance teamwork in life science research. Benchling's platform offers a range of integrated applications that are designed to speed up R&D processes at all stages. This enables scientists to design, share, and document experiments, and share DNA-sequence data via the cloud. As a result, researchers have the necessary resources to speed up, assess, and predict R&D from discovery to bioprocessing, all from a single platform.

Investors include:

Further Key Investors:

Draper Associates, Rogue Capital, Benchmark (San Francisco), ICONIQ Growth, Rock Health Capital, Elad Gil, Y Combinator, Lone Pine Capital, Ashton Kutcher, Artisanal Ventures, Lux Capital, Spark Capital, Matt Huang, Christopher Golda, Michael Montano, Thrive Capital, Adam Draper, Eight Roads, F-Prime Capital, Collective Liquidity, Foreword, Ensemble Labs, Menlo Ventures, Byers Capital, Alkeon Capital Management.

Looking to sell Benchling Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you

Management Team

Sajith WickramasekaraCo-Founder, Chief Executive Officer & Board Member

Co-Founder, Chief Executive Officer & Board Member

Ashutosh SinghalCo-Founder, President and Board Member

Co-Founder, President and Board Member

Richard WongChief Financial Officer

Chief Financial Officer

Stephen DeasyChief Technology Officer

Chief Technology Officer

Zach PowersChief Information Security Officer

Chief Information Security Officer

Lindsey IrvineChief Marketing Officer

Chief Marketing Officer

Niall WallChief Partner Officer & Head of Partners

Chief Partner Officer & Head of Partners

Shawna WolvertonChief Product Officer

Chief Product Officer

Board Members

Ashutosh SinghalBoard Member

Board Member

Eric VishriaBoard Member

Board Member

Jennifer GoldsmithBoard Member

Board Member

Krista Anderson-CoppermanBoard Member

Board Member

Miles GrimshawBoard Member

Board Member

Ron GillBoard Member

Board Member

Sajith WickramasekaraBoard Member

Board Member

William J.G. GriffithBoard Member

Board Member

Other HealthTech companies from Collective's Target Portfolio

Companies backed by the same VC's

Benchling in the News

Source: European Pharmaceutical ManufacturerZealand Pharma Partners with Benchling

Benchling announced that Zealand Pharma A/S, a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data.

Source: PRNewswireAnnouncing Benchling Bioprocess, the End-to-End Solution for Modern, High-throughput Process Development

Benchling Bioprocess delivers new design, planning, and execution capabilities on a unified platform, to address the evolving requirements of modern process development SAN FRANCISCO, Sept. 19, 2023 /PRNewswire/ -- Benchling announced Benchling Bioprocess, a …

Source: PRNewswireBenchling Delivers an Integrated R&D Ecosystem with New Product Offerings

New product features include JMP integration, BLAST, and AlphaFold to drive faster decision-making and better data-driven insights as labs scale their R&D SAN FRANCISCO, June 6, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry…

Source: PRNewswireBenchling Creates Open Source Library of Lab Instrument Data Converters

Benchling partners with Allotrope, backing industry standards and making library of open source industry data converters freely available to the scientific community SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnolo…

Source: Yahoo FinanceLife sciences software startup Benchling lays off 9% of workforce

The startup joins a growing number of U.S. firms, including Facebook-parent Meta Platforms Inc, Amazon.com Inc and several startups, to downsize its workforce

Source: PRNewswireBenchling Bolsters Commitment to Security with Type 2 SOC 2

Rigorous examination confirms Benchling offers best-in-class security to protect its global biotech customer base SAN FRANCISCO, Jan. 26, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry, announced it has successfully complete…

Source: PRN NewswireBenchling Announces New Executive Appointments and 1,000 Customer Milestone

Benchling, the R&D Cloud powering the biotechnology industry, announced the appointment of new executive leadership to its engineering and field organizations. These hires come at the same time the company achieved significant financial milestones. In the first half of its fiscal year, Benchling surpassed 1,000 customers and increased subscription revenue 90% year-over-year. Dollar-based net expansion was greater than 150%, indicative of customers rapidly growing their use of the R&D Cloud.